Supplementation with vitamins C and E inhibits the release of interleukin-6 from contracting human skeletal muscle

Journal of Physiology

Volumn 558, Issue 2, 2004, Pages 633-645

  Fischer, Christian P ^a,b   Hiscock, Natalie J ^a,c   Penkowa, Milena ^d   Basu, Samar ^e   Vessby, Bengt ^e   Kallner, Anders ^f   Sjöberg, Lars Börje ^g   Pedersen, Bente K ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

^c RMIT UNIVERSITY   (Australia)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UPPSALA UNIVERSITY   (Sweden)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g SVERIGES RIKSBANK   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLUCOSE; HYDROCORTISONE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; LIPID; MESSENGER RNA; PLACEBO;

ADULT; ARTICLE; ATTENUATION; BLOOD SAMPLING; CALCULATION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DOPPLER ECHOGRAPHY; DRUG MECHANISM; EXTENSOR MUSCLE; FEMORAL ARTERY; FEMORAL VEIN; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; KNEE; LEG BLOOD FLOW; LEG EXERCISE; LIPID PEROXIDATION; MUSCLE BIOPSY; MUSCLE CONTRACTION; MUSCLE EXERCISE; MUSCLE STRENGTH; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REST; SINGLE BLIND PROCEDURE; STATISTICAL ANALYSIS; VASTUS LATERALIS MUSCLE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; DRUG BLOOD LEVEL; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLUCOSE BLOOD LEVEL; IL 6 GENE; MALE; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RNA TRANSLATION;

ADULT; ANTIOXIDANTS; ASCORBIC ACID; BLOOD GLUCOSE; C-REACTIVE PROTEIN; EXERCISE; GENE EXPRESSION; HUMANS; HYDROCORTISONE; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-6; LIPID PEROXIDATION; MALE; MUSCLE CONTRACTION; MUSCLE, SKELETAL; SIALOGLYCOPROTEINS; VITAMIN E;

EID: 4344616150     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2004.066779     Document Type: Article

References (49)

1. Andersen P, Adams RP, Sjogaard G, Thorboe A & Saltin B (1985). Dynamic knee extension as model for study of isolated exercising muscle in humans. J Appl Physiol 59, 1647-1653.
2. Basu S (1998). Radioimmunoassay of 8-iso-prostaglandin F2alpha: an index for oxidative injury via free radical catalysed lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids 58, 319-325.
3. Beaton LJ, Allan DA, Tarnopolsky MA, Tiidus PM & Phillips SM (2002). Contraction-induced muscle damage is unaffected by vitamin E supplementation. Med Sci Sports Exerc 34, 798-805.
4. Bergstrom J (1962). Muscle electrolytes in man. Scand J Clin Laboratory Invest 68, 1-101.
5. Bethin KE, Vogt SK & Muglia LJ (2000). Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc Natl Acad Sci U S A 97, 9317-9322.
6. Bourre JM & Clement M (1996). [Vitamin E: comparison of efficiency of incorporation of alpha-tocopherol in the organs in comparison to gamma-tocopherol]. Bull Acad Natl Med 180, 813-825.
7. Brooke MH & Kaiser KK (1970). Three 'myosin adenosine triphosphatase' systems: the nature of their pH lability and sulfhydryl dependence. J Histochem Cytochem 18, 670-672.
8. Bruunsgaard H, Poulsen HE, Pedersen BK, Nyyssonen K, Kaikkonen J & Salonen JT (2003). Long-term combined supplementations with alpha-tocopherol and vitamin C have no detectable anti-inflammatory effects in healthy men. J Nutr 133, 1170-1173.
9. Castell JV, Geiger T, Gross V, Andus T, Walter E, Hirano T, Kishimoto T & Heinrich PC (1988). Plasma-clearance, organ distribution and target-cells of interleukin-6 hepatocyte-stimulating factor in the rat. European J Biochem 177, 357-361.
10. Davies KJ, Quintanilha AT, Brooks GA & Packer L (1982). Free radicals and tissue damage produced by exercise. Biochem Biophys Res Commun 107, 1198-1205.
11. Deutsch MJ & Weeks CE (1965). Microfluorometric assay for vitamin C. J Ass Offic Chem 48, 1248-1256.
12. Dill DB & Costill DL (1974). Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol 37, 247-248.
13. Febbraio MA & Pedersen BK (2002). Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 16, 1335-1347.
14. Gleeson M (2000). Interleukins and exercise. J Physiol 529, 1.
15. Heart Protection Study Collaborative Group (2002). MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360, 23-33.
16. Hiscock N, Chan MHS, Bisucci T, Darby IA & Febbraio MA (2004). Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber type specificity. FASEB J 18, 992-994.
17. Huang HY, Appel LJ, Croft KD, Miller ER III, Mori TA & Puddey IB (2002). Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial. Am J Clin Nutr 76, 549-555.
18. Kanter MM, Nolte LA & Holloszy JO (1993). Effects of an antioxidant vitamin mixture on lipid peroxidation at rest and postexercise. J Appl Physiol 74, 965-969.
19. Keller C, Steensberg A, Pilegaard H, Osada T, Saltin B, Pedersen BK & Neufer PD (2001). Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J 15, 2748-2750.
20. Kosmidou I, Vassilakopoulos T, Xagorari A, Zakynthinos S, Papapetropoulos A & Roussos C (2002). Production of interleukin-6 by skeletal myotubes: role of reactive oxygen species. Am J Respir Cell Mol Biol 26, 587-593.
21. Langberg H, Olesen JL, Gemmer C & Kjaer M (2002). Substantial elevation of interleukin-6 concentration in peritendinous tissue, in contrast to muscle, following prolonged exercise in humans. J Physiol 542, 985-990.
22. Lyngso D, Simonsen L & Bulow J (2002). Interleukin-6 production in human subcutaneous abdominal adipose tissue: the effect of exercise. J Physiol 543, 373-378.
23. Meydani M, Fielding RA, Cannon JG, Blumberg J & Evans WJ (1997). Muscle uptake of vitamin E and its association with muscle fiber type. J Nutr Biochem 8, 74-78.
24. Morrow JD, Awad JA, Boss HJ, Blair IA & Roberts LJ (1992). Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci U S A 89, 10721-10725.
25. Morrow JD, Minton TA, Badr KF & Roberts LJ (1994). Evidence That the F-2-isoprostane, 8-epi-prostaglandin F2-alpha, is formed in-vivo. Biochim Biophys Acta 1210, 244-248.
26. Naitoh Y, Fukata J, Tominaga T, Nakai Y, Tamai S, Mori K & Imura H (1988). Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. Biochem Biophys Res Commun 155, 1459-1463.
27. Nieman DC, Henson DA, McAnulty SR, McAnulty L, Swick NS, Utter AC, Vinci DM, Opiela SJ & Morrow JD (2002). Influence of vitamin C supplementation on oxidative and immune changes after an ultramarathon. J Appl Physiol 92, 1970-1977.
28. Nieman DC, Peters EM, Henson DA, Nevines EI & Thompson MM (2000). Influence of vitamin C supplementation on cytokine changes following an ultramarathon. J Interferon Cytokine Res 20, 1029-1035.
29. Nybo L, Nielsen B, Pedersen BK, Moller K & Secher NH (2002). Interleukin-6 release from the human brain during prolonged exercise. J Physiol 542, 991-995.
30. Ohrvall M, Tengblad S & Vessby B (1993). Lower tocopherol serum levels in subjects with abdominal adiposity. J Intern Med 234, 53-60.
31. Ostrowski K, Rohde T, Zacho M, Asp S & Pedersen BK (1998). Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol 508, 949-953.
32. Ostrowski K, Schjerling P & Pedersen BK (2000). Physical activity and plasma interleukin-6 in humans - effect of intensity of exercise. Eur J Appl Physiol 83, 512-515.
33. Pedersen BK, Steensberg A, Fischer C, Keller C, Ostrowski K & Schjerling P (2001). Exercise and cytokines with particular focus on muscle-derived IL-6. Exerc Immunol Rev 7, 18-31.
34. Penkowa M, Keller C, Keller P, Jauffred S & Pedersen BK (2003). Immunohistochemical detection of interleukin-6 in human skeletal muscle fibers following exercise. FASEB J 17, 2166-2168.
35. Petersen EW, Ostrowski K, Ibfelt T, Richelle M, Offord E, Halkjaer-Kristensen J & Pedersen BK (2001). Effect of vitamin supplementation on cytokine response and on muscle damage after strenuous exercise. Am J Physiol Cell Physiol 280, C1570-C1575.
36. Radegran G (1997). Ultrasound Doppler estimates of femoral artery blood flow during dynamic knee extensor exercise in humans. J Appl Physiol 83, 1383-1388.
37. Schreck R, Albermann K & Baeuerle PA (1992). Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Rad Res Comms 17, 221-237.
38. Starkie RL, Arkinstall MJ, Koukoulas I, Hawley JA & Febbraio MA (2001). Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans. J Physiol 533, 585-591.
39. Steensberg A, Febbraio MA, Osada T, Schjerling P, Van Hall G, Saltin B & Pedersen BK (2001). Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content. J Physiol 537, 633-639.
40. Steensberg A, Fischer CP, Keller C, Moller K & Pedersen BK (2003). IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab 285, E433-E437.
41. Steensberg A, Van Hall G, Osada T, Sacchetti M, Saltin B & Klarlund PB (2000). Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol 529, 237-242.
42. Stouthard JM, van der Romijn JAPT, Endert E, Klein S, Bakker PJ, Veenhof CH & Sauerwein HP (1995). Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol 268, E813-E819.
43. Thompson D, Williams C, Garcia-Roves P, McGregor SJ, McArdle F & Jackson MJ (2003). Post-exercise vitamin C supplementation and recovery from demanding exercise. Eur J Appl Physiol 89, 393-400.
44. Thompson D, Williams C, McGregor SJ, Nicholas CW, McArdle F, Jackson MJ & Powell JR (2001). Prolonged vitamin C supplementation and recovery from demanding exercise. Int J Sport Nutr Exerc Metab 11, 466-481.
45. Van Hall G, Gonzalez-Alonso J, Sacchetti M & Saltin B (1999). Skeletal muscle substrate metabolism during exercise: methodological considerations. Proc Nutr Soc 58, 899-912.
46. Van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, Hiscock N, Moller K, Saltin B, Febbraio MA & Pedersen BK (2003). Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 88, 3005-3010.
47. Vassilakopoulos T, Karatza MH, Katsaounou P, Kollintza A, Zakynthinos S & Roussos C (2003). Antioxidants attenuate the plasma cytokine response to exercise in humans. J Appl Physiol 94, 1025-1032.
48. Vivekananthan DP, Penn MS, Sapp SK, Hsu A & Topol EJ (2003). Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361, 2017-2023.
49. Vuilleumier JP & Keck E (1989). Fluorometric assay of vitamin C in biological materials using a centrifugal analyser with fluorescence attachment. J Micronutr Anal 5, 25-34.